Autolus Therapeutics plc (AUTL) Free cash flow 2016–2025
Autolus Therapeutics plc (AUTL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$302.6MFY2025 · since FY2016: -$11.7M → -$302.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$302.6M | -32.5% |
| FY2024 | -$228.3M | -45.8% |
| FY2023 | -$156.6M | -27.1% |
| FY2022 | -$123.1M | +2.8% |
| FY2021 | -$126.7M | +4.3% |
| FY2020 | -$132.4M | -10.5% |
| FY2019 | -$119.8M | -194.7% |
| FY2018 | -$40.7M | -111.4% |
| FY2017 | -$19.2M | -64.4% |
| FY2016 | -$11.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AUTL financial trends
AUTL RevenueAUTL Net incomeAUTL Net marginAUTL Gross profitAUTL Gross marginAUTL Operating incomeAUTL Operating marginAUTL Operating cash flowAUTL Capital expendituresAUTL Return on equityAUTL Stock buybacksAUTL Dividends paidAUTL Total assetsAUTL Total liabilitiesAUTL Shareholders’ equityAUTL overview →